Northrop J P, Danielsen M, Ringold G M
J Biol Chem. 1986 Aug 25;261(24):11064-70.
We have used a glucocorticoid receptor cDNA isolated from a mouse lymphoma cell line to characterize receptor mRNA and genomic sequences present in wild type and mutant rat hepatoma (HTC) and mouse thymoma (S49 and WEHI7) cells. Wild type rat and mouse cell lines contain two receptor mRNAs, 5 and 7 kilobase pairs (kb) in length, which differ in the length of their 3'-untranslated regions. Levels of receptor mRNA present in mutant HTC, WEHI7, and S49 cells of the r- (receptorless) phenotype are decreased compared to wild type cells. This decreased level of receptor mRNA parallels the decreased level of total immunoreactive receptor protein found in these cells. S49 nt- (nuclear transfer minus) cells contain receptor mRNA levels which parallel their hormone binding and immunoreactive receptor levels. Cells of the r- and nt- phenotype contain no detectable deletions or rearrangements of the receptor gene. We conclude that r- cells have lesions which affect the expression of receptor mRNA. Surprisingly, HTC cells of the r- phenotype differ from WEHI7 and S49 r- cells in that HTC r- cells contain a lower level of receptor DNA than does their parental wild type cell line. Although these cells may contain multiple lesions, it appears that loss of receptor genomic sequences is responsible, in part, for the phenotype of the HTC r- cells. The S49 nti (nuclear transfer increase) cells produce glucocorticoid receptors of molecular weights 40,000 and 94,000. These cells produce, in addition to the wild type 5- and 7-kb receptor mRNAs, two other receptor messages 5.5 and 3.5 kb in length. RNA blot analysis using various portions of our receptor cDNA indicates that these are 5' truncated messages and suggests that the 40-kDa nti receptor is truncated at its NH2-terminal end. These data also indicate that the hormone and DNA-binding regions of the receptor are located in the COOH-terminal half of the protein.
我们使用从小鼠淋巴瘤细胞系分离得到的糖皮质激素受体cDNA,来表征野生型和突变型大鼠肝癌(HTC)以及小鼠胸腺瘤(S49和WEHI7)细胞中存在的受体mRNA和基因组序列。野生型大鼠和小鼠细胞系含有两种受体mRNA,长度分别为5和7千碱基对(kb),它们3'-非翻译区的长度不同。与野生型细胞相比,r-(无受体)表型的突变型HTC、WEHI7和S49细胞中存在的受体mRNA水平降低。受体mRNA水平的这种降低与这些细胞中发现的总免疫反应性受体蛋白水平的降低相一致。S49 nt-(核转运减)细胞的受体mRNA水平与它们的激素结合和免疫反应性受体水平相一致。r-和nt-表型的细胞未检测到受体基因的缺失或重排。我们得出结论,r-细胞存在影响受体mRNA表达的损伤。令人惊讶的是,r-表型的HTC细胞与WEHI7和S49 r-细胞不同,因为HTC r-细胞所含的受体DNA水平低于其亲本野生型细胞系。尽管这些细胞可能存在多种损伤,但似乎受体基因组序列的缺失部分导致了HTC r-细胞的表型。S49 nti(核转运增)细胞产生分子量为40,000和94,000的糖皮质激素受体。除了野生型5-和7-kb受体mRNA外,这些细胞还产生另外两种长度分别为5.5和3.5 kb的受体信使RNA。使用我们受体cDNA的不同部分进行RNA印迹分析表明,这些是5'端截短的信使RNA,并表明40-kDa nti受体在其NH2末端被截短。这些数据还表明,受体的激素结合和DNA结合区域位于蛋白质的COOH末端一半。